EP3534913A1 - Zusammensetzung und verfahren zur behandlung von otitis - Google Patents

Zusammensetzung und verfahren zur behandlung von otitis

Info

Publication number
EP3534913A1
EP3534913A1 EP17868280.3A EP17868280A EP3534913A1 EP 3534913 A1 EP3534913 A1 EP 3534913A1 EP 17868280 A EP17868280 A EP 17868280A EP 3534913 A1 EP3534913 A1 EP 3534913A1
Authority
EP
European Patent Office
Prior art keywords
composition
pvp
dmso
composition comprises
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17868280.3A
Other languages
English (en)
French (fr)
Other versions
EP3534913A4 (de
Inventor
Joseph CAPRIOTTI
Kara CAPRIOTTI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Veloce Biopharma LLC
Original Assignee
Veloce Biopharma LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/341,930 external-priority patent/US20170071979A1/en
Application filed by Veloce Biopharma LLC filed Critical Veloce Biopharma LLC
Publication of EP3534913A1 publication Critical patent/EP3534913A1/de
Publication of EP3534913A4 publication Critical patent/EP3534913A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
EP17868280.3A 2016-11-02 2017-11-01 Zusammensetzung und verfahren zur behandlung von otitis Withdrawn EP3534913A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/341,930 US20170071979A1 (en) 2011-05-11 2016-11-02 Composition and method for treating otitis
PCT/US2017/059513 WO2018085384A1 (en) 2016-11-02 2017-11-01 Composition and method for treating otitis

Publications (2)

Publication Number Publication Date
EP3534913A1 true EP3534913A1 (de) 2019-09-11
EP3534913A4 EP3534913A4 (de) 2020-07-15

Family

ID=60860035

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17868280.3A Withdrawn EP3534913A4 (de) 2016-11-02 2017-11-01 Zusammensetzung und verfahren zur behandlung von otitis

Country Status (5)

Country Link
EP (1) EP3534913A4 (de)
JP (3) JP6255134B1 (de)
KR (3) KR20180061359A (de)
CN (1) CN108472313A (de)
WO (1) WO2018085384A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021161105A (ja) * 2020-03-31 2021-10-11 タイ ミン ファーマシューティカルズ ジェイエスシー ヒト又は動物の慢性若しくは急性のウイルス感染症及び／又は敗血症の予防若しくは治療のための組成物
TW202203946A (zh) * 2020-03-31 2022-02-01 越南商泰明製藥股份有限公司 用於人或動物之慢性或急性之病毒感染症及/或敗血症之預防或治療的組成物
FR3122572A1 (fr) * 2021-05-07 2022-11-11 Nadine GRISLAIN Composition pharmaceutique bioadhésive comprenant du PVPI

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241051A (en) * 1977-11-04 1980-12-23 Christie Robert B Calcitonin
WO2006099325A2 (en) * 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of treating ear infections
DE202005004183U1 (de) * 2005-03-14 2005-05-25 G. Pohl-Boskamp Gmbh & Co. Kg Ohrentropfen zum Einbringen in den Gehörgang
US20060280809A1 (en) * 2005-06-14 2006-12-14 Leshchiner Adele K Anti-infective iodine based compositions for otic and nasal use
CN101002775A (zh) * 2006-01-18 2007-07-25 广州白云山制药股份有限公司广州白云山制药总厂 一种抗感染制剂
GB0709513D0 (en) * 2007-05-17 2007-06-27 Helperby Therapeutics Ltd Topical formulations
US20090263345A1 (en) * 2008-01-28 2009-10-22 Foresight Biotherapeutics, Inc. Otic compositions for the treatment of infections of the internal and external ear in mammals
US20100016450A1 (en) * 2008-07-21 2010-01-21 Otonomy, Inc. Controlled release delivery devices for the treatment of otic disorders
CN104906580A (zh) * 2009-12-15 2015-09-16 前瞻生物治疗公司 无刺激性眼科聚维酮碘组合物
MX337419B (es) * 2010-01-07 2016-03-03 Univ Minnesota Metodos y composiciones para aplicar moxifloxacina al oido.
PL2366408T3 (pl) * 2010-03-01 2013-01-31 Salvat Lab Sa Klarowne roztwory wodne acetonidu fluocinolonu do leczenia zapalenia uszu
ES2665986T3 (es) * 2011-05-11 2018-04-30 Veloce Biopharma Llc Composiciones antifúngicas para el tratamiento de las uñas
TW201325601A (zh) * 2011-09-16 2013-07-01 Foresight Biotherapeutics Inc 安定之普維酮－碘組成物
WO2014159930A1 (en) * 2013-03-14 2014-10-02 Alc Therapeutics, Llc Antifungal compositions for the treatment of secondary skin and nail infections
JP6254257B2 (ja) * 2013-05-01 2017-12-27 ネオクリ ピーティーワイ リミテッド 細菌感染を処置するための方法
AU2016209550A1 (en) * 2015-01-20 2017-08-03 Veloce Biopharma Llc Novel iodophor composition and methods of use

Also Published As

Publication number Publication date
JP2018070583A (ja) 2018-05-10
JP2018070655A (ja) 2018-05-10
JP6271804B1 (ja) 2018-01-31
KR20180061359A (ko) 2018-06-07
EP3534913A4 (de) 2020-07-15
KR20180059554A (ko) 2018-06-04
JP2018070620A (ja) 2018-05-10
CN108472313A (zh) 2018-08-31
JP6255134B1 (ja) 2017-12-27
KR20190100442A (ko) 2019-08-28
WO2018085384A1 (en) 2018-05-11

Similar Documents

Publication Publication Date Title
AU2016203574B2 (en) Otic compositions useful for the treatment of infections of the internal and external ear in mammals
US20210177882A1 (en) Treatment of Inflammatory Lesions of Rosacea with Ivermectin
US10398725B2 (en) Ophthalmic compositions and methods of use
JP6271804B1 (ja) 耳炎の治療のための組成物および方法
KR20180011883A (ko) 신규한 요오드포 조성물 및 사용 방법
US20170071979A1 (en) Composition and method for treating otitis
Yapar et al. A RECENT OVERVIEW OF LOCALLY ADMINISTERED TOPICAL OTIC DOSAGE FORMS

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190531

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20200616

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 31/04 20060101ALI20200609BHEP

Ipc: A61P 27/16 20060101ALI20200609BHEP

Ipc: A61P 31/10 20060101ALI20200609BHEP

Ipc: A61K 47/58 20170101ALI20200609BHEP

Ipc: A61P 33/04 20060101ALI20200609BHEP

Ipc: A61K 47/38 20060101ALI20200609BHEP

Ipc: A61K 9/06 20060101ALI20200609BHEP

Ipc: A61K 9/00 20060101ALI20200609BHEP

Ipc: A61K 47/06 20060101ALI20200609BHEP

Ipc: A61P 31/12 20060101ALI20200609BHEP

Ipc: A61P 31/02 20060101ALI20200609BHEP

Ipc: A61K 47/32 20060101ALI20200609BHEP

Ipc: A61K 33/18 20060101AFI20200609BHEP

Ipc: A61K 47/10 20170101ALI20200609BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20220601